Grant: Collaborative Health Research Projects
University of Toronto
$84,167.00
ARRT: Adaptive and Robust Radiation Therapy treatment planning for lung cancer
FY 2011-12
Summary
Lung cancer is the leading cause of cancer death in Canada and worldwide. Improving current methods of treatment is paramount to increasing survival and reducing the rising costs of managing this disease. Radiation therapy is a core technology used to treat lung cancer. Radiation is delivered to the patient using external beams of high energy x-rays aimed at the tumor. However, there are several challenges associated with delivering high quality treatments. First, since radiation damages healthy tissue, the amount of radiation delivered to the tumour is limited by the radiation tolerance of nearby organs such as the lung, heart, and spinal cord. Second, lung tumours are subject to irregular movements caused by patient breathing. As a result, the radiation beam may miss part of the target or may end up delivering increased dose to the healthy tissue. Third, the tumour's size, geometry and metabolic activity will change over the course of a typical multi-week
treatment. Current clinical protocols typically do not adapt to these changes. The goal of our research is to improve the efficacy of radiation therapy treatments for lung cancer. In this project, we will address current limitations by developing a new treatment planning method based on sophisticated mathematical techniques. We will develop a mathematical model that optimizes treatments and, in comparison to traditional methods, allows more dose to be delivered to the tumour while keeping dose to the healthy tissues low. Our model will account for the presence of healthy lung tissue, the motion of the tumour
during treatment, and the evolution of the tumour's characteristics over multiple weeks. We will test our methodology on clinical data, and we will develop protocols to ensure such advanced treatments can be delivered within the clinical constraints under which hospitals currently operate. Our collaborative team brings together researchers from both engineering and health sciences to pursue this innovative research project. In the long term, our technology has the potential to impact therapies for many types of cancer and to improve the health of cancer patients in Canada and worldwide.
Program
Collaborative Health Research Projects
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
398106-2011
Name nom
Chan, Timothy
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
84167
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Partie
1
Nb partie
3
Application title
ARRT: Adaptive and Robust Radiation Therapy treatment planning for lung cancer
Keyword
NSERC
Application summary
Lung cancer is the leading cause of cancer death in Canada and worldwide. Improving current methods of treatment is paramount to increasing survival and reducing the rising costs of managing this disease. Radiation therapy is a core technology used to treat lung cancer. Radiation is delivered to the patient using external beams of high energy x-rays aimed at the tumor. However, there are several challenges associated with delivering high quality treatments. First, since radiation damages healthy tissue, the amount of radiation delivered to the tumour is limited by the radiation tolerance of nearby organs such as the lung, heart, and spinal cord. Second, lung tumours are subject to irregular movements caused by patient breathing. As a result, the radiation beam may miss part of the target or may end up delivering increased dose to the healthy tissue. Third, the tumour's size, geometry and metabolic activity will change over the course of a typical multi-week
treatment. Current clinical protocols typically do not adapt to these changes. The goal of our research is to improve the efficacy of radiation therapy treatments for lung cancer. In this project, we will address current limitations by developing a new treatment planning method based on sophisticated mathematical techniques. We will develop a mathematical model that optimizes treatments and, in comparison to traditional methods, allows more dose to be delivered to the tumour while keeping dose to the healthy tissues low. Our model will account for the presence of healthy lung tissue, the motion of the tumour
during treatment, and the evolution of the tumour's characteristics over multiple weeks. We will test our methodology on clinical data, and we will develop protocols to ensure such advanced treatments can be delivered within the clinical constraints under which hospitals currently operate. Our collaborative team brings together researchers from both engineering and health sciences to pursue this innovative research project. In the long term, our technology has the potential to impact therapies for many types of cancer and to improve the health of cancer patients in Canada and worldwide.